Day: March 22, 2021

Savosolar Plc – Managers’ Transaction, Eero Auranne, March 2021

Written by Customer Service on March 22, 2021. Posted in Public Companies.

Savosolar PlcCompany Announcement 22 March 2021 at 11.45 a.m. (CET)Savosolar Plc – Managers’ Transaction, Eero Auranne, March 2021 Person subject to the notification requirementName: Auranne, Eero Kalevi Position: Member of the Board/Deputy member Initial Notification Reference number: 743700J1YZ8IEJAPDL21_20210322102438_3 IssuerName: Savosolar OyjLEI: 743700J1YZ8IEJAPDL21 Transaction detailsTransaction date: 2021-03-18Venue: FIRST NORTH FINLAND (FNFI)Nature of the transaction: Subscription Instrument: ShareISIN: FI4000425848 Volume: 10095Unit price: 0.09600 Euro Aggregated transactionsVolume: 10095Volume weighted average price: 0.09600 EuroSAVOSOLAR PLC For more information: Savosolar PlcManaging Director Jari VarjotiePhone: +358...

Savosolar Oyj – Johdon liiketoimet, Eero Auranne, maaliskuu 2021

Written by Customer Service on March 22, 2021. Posted in Public Companies.

Savosolar OyjYhtiötiedote 22.3.2021 klo 11.45 (CET)Savosolar Oyj – Johdon liiketoimet, Eero Auranne, maaliskuu 2021 IlmoitusvelvollinenNimi: Auranne, Eero Kalevi Asema: Hallituksen jäsen/varajäsen Ensimmäinen ilmoitus Viitenumero: 743700J1YZ8IEJAPDL21_20210322102438_3 LiikkeeseenlaskijaNimi: Savosolar OyjLEI: 743700J1YZ8IEJAPDL21 Liiketoimien yksityiskohtaiset tiedotLiiketoimen päivämäärä: 2021-03-18Kauppapaikka: FIRST NORTH FINLAND (FNFI)Liiketoimen luonne: Merkintä Instrumentti: OsakeISIN: FI4000425848 Volyymi: 10095Yksikköhinta: 0.09600 Euro SAVOSOLAR OYJ Lisätietoja: Toimitusjohtaja Jari VarjotiePuh: +358 400 419 734Sähköposti: jari.varjotie@savosolar.com Savosolar lyhyestiSavosolarin erittäin tehokkaat keräimet ja suuren mittakaavan...

Tauriga Sciences, Inc. Converts its U.S. Provisional Patent Application (Filed on March 17, 2020) to a U.S. Non-Provisional Patent Application

Written by Customer Service on March 22, 2021. Posted in Public Companies.

To Enhance Its Existing Intellectual Property Portfolio, the Company Filed an Additional U.S. Provisional Patent Application Directed to: Alternative Pharmaceutical Cannabinoid Delivery Systems NEW YORK, NY, March 22, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant), additional product offerings, as well as an ongoing Pharmaceutical Development initiative, today announced that on March 17, 2021, the Company converted its U.S. Provisional Patent Application (filed on March 17, 2020) to a U.S. Non-Provisional Patent Application. This Non-Provisional Patent...

Akero Therapeutics to Announce New Data from an Evaluation of Efruxifermin (EFX) in Cirrhotic NASH (F4) Patients

Written by Customer Service on March 22, 2021. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., March 22, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH), today announced that the company plans to discuss new efficacy and safety data, including biopsy results, from an expansion cohort of a 16-week Phase 2a clinical trial, Cohort C, evaluating efruxifermin (EFX) in the treatment of adult patients with cirrhotic nonalcoholic steatohepatitis (NASH) in a post-market press release and webcast to be held today, March 22, 2021. Conference Call / Webcast DetailsThe company will host a conference call and webcast with slide presentation at 4:30 p.m. ET (1:30 p.m. PT) this afternoon, March 22, 2021. The webcast of the conference call will be made available on the company’s...

SpringWorks Therapeutics Appoints Bhavesh Ashar as Chief Commercial Officer

Written by Customer Service on March 22, 2021. Posted in Public Companies.

STAMFORD, Conn., March 22, 2021 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, announced today that Bhavesh Ashar has been appointed Chief Commercial Officer. Mr. Ashar has more than 20 years of global pharmaceutical and biotechnology experience, most recently having served as Senior Vice President, General Manager of U.S. Oncology at Bayer Healthcare. Mr. Ashar will build and lead commercial operations at SpringWorks as the company continues to advance its diversified targeted oncology portfolio, which includes two potentially registrational rare oncology programs.

TCM Groups A/S: Notice Annual General Meeting

Written by Customer Service on March 22, 2021. Posted in Public Companies.

COMPANY ANNOUNCEMENT No. 75/2021 Tvis, 22 March 2021 The annual general meeting of TCM Group A/S will be held on the 13th of April 2021 at 5 p.m. (CEST) at Skautrupvej 22b, Tvis, 7500 Holstebro, Denmark (see however Covid-19 precautions in the notice). The notice and the agenda for the annual general meeting are attached to this announcement. For further information please contact:Torben Paulin, CEO, TCM Group A/S, +45 21 21 04 64 About TCM Group TCM Group is Scandinavia’s third largest manufacturer of kitchens and furniture for bathrooms and storage. The products are Danish design, produced in Denmark and rooted in a proud tradition of good quality and good craftsmanship. TCM Group pursues a multi-brand strategy, under...

TCM Group A/S: Indkaldelse til generalforsamling

Written by Customer Service on March 22, 2021. Posted in Public Companies.

SELSKABSMEDDELELSE Nr. 75/2021 Tvis, 22. marts 2021 TCM Group A/S afholder ordinær generalforsamling den 13. april 2021 kl. 17:00 på selskabets adresse, Skautrupvej 22b, Tvis, 7500 Holstebro (jf. dog i indkaldelsen til generalforsamlingen om Covid-19 foranstaltninger). Indkaldelse til og dagsorden for generalforsamlingen er vedlagt denne meddelelse. For yderligere information:Torben Paulin, CEO TCM Group A/S +45 21 21 04 64 Om TCM Group TCM Group er Skandinaviens tredjestørste producent af køkkener og badeværelses- og opbevaringsmøbler. Produkterne er dansk design, produceres i Danmark og er rodfæstet i en stolt tradition for kvalitet og solidt håndværk. TCM Group fører en multibrand-strategi, hvor Svane Køkkenet er det...

Capital Digestive Care Partners with Temple Hills Gastroenterology, Expanding Gastroenterology Services in Prince George’s County, Maryland

Written by Customer Service on March 22, 2021. Posted in Mergers And Acquisitions.

Silver Spring, MD, March 22, 2021 (GLOBE NEWSWIRE) — Capital Digestive Care, the largest private gastroenterology practice in the Mid-Atlantic, is pleased to announce a new partnership with independent gastroenterology practice Temple Hills Gastroenterology. This partnership will expand Capital Digestive Care’s reach in southern Maryland and will help meet the needs of patients and physician groups in the underserved Temple Hills community in Prince George’s County. Temple Hills Gastroenterology has been treating Prince George’s County residents for 35 years. The practice’s two providers are an experienced father and son team – Dr. Abdulhosein Adham and Dr. Kasra Adham. Both physicians are experts in the evaluation and treatment of digestive and liver diseases and are committed to providing compassionate, high-quality, patient-centered...

Central Nervous System Treatment Market to Reach USD 166.53 Billion with a CAGR of 9.4% by 2028; Rising Cases of Neurological Disorders to Propel Growth: states Fortune Business Insights™

Written by Customer Service on March 22, 2021. Posted in Mergers And Acquisitions.

Pune, India, March 22, 2021 (GLOBE NEWSWIRE) — The global central nervous system treatment market size is expected to reach USD 166.53 billion by 2028, exhibiting a CAGR of 9.4% during the forecast period. The surge in chronic neurological illness among patients can have an impressive effect on the market growth in the forthcoming years, states Fortune Business Insights, in a report, titled “Central Nervous System Treatment Market, 2021-2028.” The market size stood at USD 81.67 billion in 2020. COVID-19 Impact: Massive Revenue Drop of CNS Drugs Amid COVID-19 The coronavirus outbreak has notably hindered the supply chain of CNS drugs in the market. The shifted focus towards R&D of COVID-19 therapeutics and vaccines have caused immense loss to the CNS industry. Over-the-counter products such as analgesics and products such as...

Buy-back yield SGB IL 3108 2021-03-22

Written by Customer Service on March 22, 2021. Posted in Public Companies.

2021-03-22 Buy-back yield SGB IL 3108; -1.1750% The buy-back yield of SGB IL 3108 is the yield at which the SNDO will buy SGB IL 3108 in the switch auction vs SGB IL 3112 on March 22, 2021. For more information, please contact: The funding desk+ 46 8 613 4780FO@riksgalden.se

Day: March 22, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals